Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06
Open Access
- 1 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 62 (Supplement) , ii75-ii85
- https://doi.org/10.1093/jac/dkn354
Abstract
To describe the current patterns and trends in antimicrobial susceptibility in enterococci and streptococci (excepting pneumococci) from bacteraemia in the UK and Ireland from 2001 to 2006. In each year 2001–06, blood culture isolates were collected by 25 laboratories distributed across the UK and Ireland. In total, there were 1408 isolates of enterococci, 1332 of β-haemolytic streptococci and 1012 of α- and non-haemolytic streptococci. A single central laboratory re-identified the isolates and measured MICs by the BSAC agar dilution method. The prevalence of reduced susceptibility in streptococci and enterococci did not change significantly for most antibiotics, but trends were noted to increased ampicillin, imipenem and vancomycin resistance in Enterococcus faecium. The prevalence of reduced susceptibility to macrolides and tetracycline in streptococci, to tetracycline and gentamicin (high level) in enterococci and to β-lactams and glycopeptides in E. faecium were all high, with some differences in the prevalence among species or groups. Reduced susceptibility to some antimicrobial agents among streptococci and enterococci remains common and continued surveillance is warranted.Keywords
This publication has 44 references indexed in Scilit:
- Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007Journal of Antimicrobial Chemotherapy, 2008
- Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistanceJournal of Antimicrobial Chemotherapy, 2004
- Infections Caused by Viridans Streptococci in Patients with NeutropeniaClinical Infectious Diseases, 2002
- Infective Endocarditis in AdultsNew England Journal of Medicine, 2001
- In Vitro Activities of the New Ketolide HMR 3647 (Telithromycin) in Comparison with Those of Eight Other Antibiotics against Viridans Group Streptococci Isolated from Blood of Neutropenic Patients with CancerAntimicrobial Agents and Chemotherapy, 2001
- Nosocomial streptococcal blood stream infections in the SCOPE program: Species occurrence and antimicrobial resistanceDiagnostic Microbiology and Infectious Disease, 1997
- In vitro evaluation of contemporary β-lactam drugs tested against viridans group and β-haemolytic streptococciDiagnostic Microbiology and Infectious Disease, 1997
- Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart AssociationPublished by American Medical Association (AMA) ,1995
- Bacteremia Due to Viridans Streptococci That Are Highly Resistant to Penicillin: Increase Among Neutropenic Patients with CancerClinical Infectious Diseases, 1995
- The life and times of the EnterococcusClinical Microbiology Reviews, 1990